543. Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol
Publication
, Journal Article
Rauseo, A; Der, T; Alicic, R; Balani, B; Morse, C; Zakroysky, P; Shaw, L; Atkinson, J; Powderly, WG
Published in: Open Forum Infectious Diseases
November 27, 2023
Duke Scholars
Published In
Open Forum Infectious Diseases
DOI
EISSN
2328-8957
Publication Date
November 27, 2023
Volume
10
Issue
Supplement_2
Publisher
Oxford University Press (OUP)
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rauseo, A., Der, T., Alicic, R., Balani, B., Morse, C., Zakroysky, P., … Powderly, W. G. (2023). 543. Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol. Open Forum Infectious Diseases, 10(Supplement_2). https://doi.org/10.1093/ofid/ofad500.612
Rauseo, Adriana, Tatyana Der, Radica Alicic, Bindu Balani, Caryn Morse, Pearl Zakroysky, Linda Shaw, Jane Atkinson, and William G. Powderly. “543. Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol.” Open Forum Infectious Diseases 10, no. Supplement_2 (November 27, 2023). https://doi.org/10.1093/ofid/ofad500.612.
Rauseo A, Der T, Alicic R, Balani B, Morse C, Zakroysky P, et al. 543. Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol. Open Forum Infectious Diseases. 2023 Nov 27;10(Supplement_2).
Rauseo, Adriana, et al. “543. Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol.” Open Forum Infectious Diseases, vol. 10, no. Supplement_2, Oxford University Press (OUP), Nov. 2023. Crossref, doi:10.1093/ofid/ofad500.612.
Rauseo A, Der T, Alicic R, Balani B, Morse C, Zakroysky P, Shaw L, Atkinson J, Powderly WG. 543. Sex Differences in Clinical Presentation and Outcomes of Adults Hospitalized with COVID-19 Pneumonia After Administration of Infliximab, Abatacept or Cenicriviroc: Subgroup Analysis from the ACTIV-1 Master Protocol. Open Forum Infectious Diseases. Oxford University Press (OUP); 2023 Nov 27;10(Supplement_2).
Published In
Open Forum Infectious Diseases
DOI
EISSN
2328-8957
Publication Date
November 27, 2023
Volume
10
Issue
Supplement_2
Publisher
Oxford University Press (OUP)
Related Subject Headings
- 3207 Medical microbiology
- 3202 Clinical sciences